Tumor-induced disruption of proximal TCR-mediated signal transduction in tumor-infiltrating CD8+ lymphocytes inactivates antitumor effector phase
about
The dual role of complement in cancer and its implication in anti-tumor therapyThe application of the fibroblast activation protein α-targeted immunotherapy strategyCish actively silences TCR signaling in CD8+ T cells to maintain tumor toleranceExpansion of interferon-gamma-producing multifunctional CD4+ T-cells and dysfunctional CD8+ T-cells by glypican-3 peptide library in hepatocellular carcinoma patients.Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumorsLoss of the promyelocytic leukemia protein in gastric cancer: implications for IP-10 expression and tumor-infiltrating lymphocytes.The CD3-zeta chimeric antigen receptor overcomes TCR Hypo-responsiveness of human terminal late-stage T cells.Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization.Protocadherin-18 is a novel differentiation marker and an inhibitory signaling receptor for CD8+ effector memory T cells.Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine-Dependent Arrest in the T-cell Signaling Cascade.Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer.T-cell modulatory properties of CD5 and its role in antitumor immune responsesA Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors.Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft model.PD-1 targeting in cancer immunotherapy.Enhanced function of cytotoxic T lymphocytes induced by dendritic cells modified with truncated PSMA and 4-1BBL.Level of circulating PD-L1 expression in patients with advanced gastric cancer and its clinical implications.Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance.Positive and negative influence of the matrix architecture on antitumor immune surveillance.Spontaneous remission of acute myeloid leukemia.Giving oncolytic vaccinia virus more BiTE.Tumor-infiltrating CD45RO(+) memory cells are associated with a favorable prognosis breast cancer.Exosomes Associated with Human Ovarian Tumors Harbor a Reversible Checkpoint of T-cell Responses.
P2860
Q26738682-060108EE-E1DE-4C5D-A6A8-73BA2EA94E05Q28073437-D53C145A-778D-4623-A36D-C595356F9C39Q28269352-688070B8-0B69-4985-BB7A-CA3935FB8D21Q33850655-E58B07FE-8B57-44CF-8424-52807889EA59Q34052580-D0632B60-0314-4963-888A-E0C431B4F224Q34056212-2B77C27D-7BB1-44D4-85F2-F6ADC8E09717Q34146327-E37ACF3C-BC41-47DF-BEDC-F85C786F9284Q34162609-C42DE7A7-AC94-43E8-B3F6-89C8C131DE46Q34261705-D8FB96B0-09E1-48D2-8863-2A5BC2547549Q36259431-4A494867-7AD6-4264-9292-6FF5568BD50BQ36471557-51D20264-B045-41E1-8FDE-EDA00E2EFCCBQ36643675-3568FEB8-5E29-41DF-ADAD-EEE1F82F7F8AQ36709308-CDAA8E1F-5F13-4D54-AD20-5B629D9617CCQ37040202-B10382E0-9C29-45AF-B6FD-C34B09B48CF2Q37179069-66345D69-DA3C-45B8-9B1A-74C2045364E9Q37521861-74000C7E-88EE-4A79-B2E8-97C201DC026CQ37608658-2981D946-7E71-43A6-B3FD-DC3942D2E5CBQ37873379-79EABB2E-55C7-4E05-B6CE-79053B1FB836Q37945304-D0A976AF-F5CC-4C5B-A624-B94E749DC64EQ38104594-77F6FE41-E472-4966-BD46-1D75A19181C3Q38256921-97246FB4-44BA-4A98-9981-B7977F10C1EBQ38648659-BF4AFFEF-B21D-4582-94C2-D50765B7165BQ41673328-87E7D256-E77C-4B5B-82F2-AA37496C38F5Q47558029-A1184DB4-7655-489F-9D23-FF2CF537D92D
P2860
Tumor-induced disruption of proximal TCR-mediated signal transduction in tumor-infiltrating CD8+ lymphocytes inactivates antitumor effector phase
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor-induced disruption of pr ...... vates antitumor effector phase
@en
Tumor-induced disruption of pr ...... ates antitumor effector phase.
@nl
type
label
Tumor-induced disruption of pr ...... vates antitumor effector phase
@en
Tumor-induced disruption of pr ...... ates antitumor effector phase.
@nl
prefLabel
Tumor-induced disruption of pr ...... vates antitumor effector phase
@en
Tumor-induced disruption of pr ...... ates antitumor effector phase.
@nl
P2093
P2860
P356
P1476
Tumor-induced disruption of pr ...... vates antitumor effector phase
@en
P2093
Alan B Frey
Edwin J Vazquez-Cintron
Ngozi R Monu
P2860
P304
P356
10.4049/JIMMUNOL.1001157
P407
P577
2010-12-01T00:00:00Z